je.st
news
Biotech Deserves A Piece Of Every Dividend Growth Portfolio
2016-01-26 07:14:29| Biotech - Topix.net
Taking into account their projected EPS growth rates and potential for dividend growth, both companies, but in particular Gilead Sciences, are attractively valued relative to the market. Amgen became a pioneer in the biotech world when it became the first large biotech stock to begin paying a regular dividend in 2011.
Tags: growth
piece
portfolio
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||